Company description

Cerenion Oy develops the world’s first practical method for measuring the brain function of intensive care patients. Cerenion C-Trend™ technology (pat. pend.) aims to reveal the status of the brain as one simple score – at the bed-side and without requiring any changes to the care of the patient. The solution works by combining standard EEG-measurement with advanced machine learning algorithms and artificial intelligence. The technology has the potential of improving both the quality and the cost of intensive care.

Business sector

Health & Life Science, Health technology and eHealth, Healthcare and Wellness services, ICT, Life Science, pharmaceutical, SW-products

AI, Artificial intelligence, AI, B2B, Health, HealthTech, Monitoring, Social and health care systems